Atrial Fibrillation with Rapid Ventricular Response

• CLINICAL_TRIALS trial_result · 2023-01-20
  Clinical Trial Update: Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response [Phase 2]

  Phase 2 trial exploring pre-diltiazem calcium versus placebo for atrial fibrillation with rapid ventricular response, status unknown.

• FDA approval · 2022-12-13
  FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approved Amneal Pharmaceuticals' Esmolol hydrochloride in sodium chloride as a generic injectable under an Original Application (ANDA).